|Bid||35.35 x 2900|
|Ask||40.00 x 800|
|Day's Range||35.12 - 37.24|
|52 Week Range||33.50 - 56.40|
|Beta (5Y Monthly)||1.46|
|PE Ratio (TTM)||31.44|
|Earnings Date||Feb 21, 2022 - Feb 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||52.27|
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it will participate at the following investor conferences:
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
View more earnings on HALOSee more from BenzingaClick here for options trades from BenzingaPerkinElmer Q3 Earnings, FY21 Guidance Beat Wall Street ExpectationsOcugen's India Partnered COVID-19 Vaccine Gets WHO Approval: Report© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.